Watch Ticker

Aptorum Group Limited Class A Ordinary Shares

Go to Aptorum Group Limited Class A Ordinary Shares Website

$1.37

-0.05 (-3.52%)

Live

Previous Close

$1.42

Day Range

$1.34 - $1.41

Previous Day Range

$1.37 - $1.49

Market Cap

$9.8 million USD

Day Vol.

76999

Previous Day Vol.

247712

Currency

USD

Primary Exchange

Nasdaq

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indic...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement

Aptorum Group Limited and DiamiR Biosciences have signed a definitive merger agreement, where DiamiR will become a wholly-owned subsidiary of Aptorum. The all-stock transaction will result in DiamiR shareholders owning approximately 70% of the combined company, with the merger expected to close in Q4 2025.

Related tickers: APM.

Read Full Article

N/A - Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering

Aptorum Group, a clinical-stage biopharmaceutical company, announced a $3 million registered direct offering of 1,535,000 Class A Ordinary Shares at $2.00 per share. The offering is expected to close on January 3, 2025, subject to customary closing conditions.

Related tickers: APM.

Read Full Article

Trending Tickers

Please sign in to view